Drug Trial Radar · NCT07494409
A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Oct 31, 2025
Primary completion
Feb 20, 2027
Study completion Oct 30, 2027
Sponsor
- Lead sponsor
- Kind Pharmaceuticals LLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)
Conditions
- Anemia Due to Chronic Kidney Disease
Interventions
AND017 capsulesDrug
AND017 capsules administered orally with a starting dose of 10 mg TIW
ESADrug
ESA injection and dose based on package insert and local practice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the efficacy of AND017 compared with the active control in maintaining Hb levels in anemic patients with ESKDTime frame: From Week 23 to Week 27
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fudan Univeristy Zhongshan Hospital
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.